DIA459.32-2.60 -0.56%
SPX6,584.29-3.18 -0.05%
IXIC22,141.10+98.03 0.45%

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Benzinga·09/03/2025 12:08:15
Listen to the news

Gainers

  • SINTX Technologies (NASDAQ:SINT) stock rose 22.5% to $5.6 during Wednesday's pre-market session. The market value of their outstanding shares is at $12.6 million.
  • Connect Biopharma Hldgs (NASDAQ:CNTB) stock increased by 17.05% to $2.47. The market value of their outstanding shares is at $117.5 million.
  • Akanda (NASDAQ:AKAN) shares moved upwards by 15.05% to $4.05. The market value of their outstanding shares is at $2.5 million.
  • Addex Therapeutics (NASDAQ:ADXN) shares increased by 12.36% to $9.09. The market value of their outstanding shares is at $8.6 million. As per the press release, Q2 earnings came out 2 days ago.
  • Check-Cap (NASDAQ:CHEK) shares moved upwards by 11.9% to $0.78. The company's market cap stands at $4.0 million.
  • Aethlon Medical (NASDAQ:AEMD) stock increased by 9.75% to $1.8. The company's market cap stands at $4.2 million.

Losers

  • WAVE Life Sciences (NASDAQ:WVE) stock decreased by 20.2% to $7.68 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.5 billion.
  • Strata Skin Sciences (NASDAQ:SSKN) shares fell 16.97% to $2.35. The company's market cap stands at $11.8 million.
  • Purple Biotech (NASDAQ:PPBT) stock declined by 15.49% to $1.2. The company's market cap stands at $3.7 million.
  • Zentek (NASDAQ:ZTEK) stock declined by 13.61% to $0.78. The company's market cap stands at $94.5 million.
  • CARISMA Therapeutics (NASDAQ:CARM) shares declined by 11.44% to $0.39. The company's market cap stands at $18.3 million.
  • SAB Biotherapeutics (NASDAQ:SABS) shares declined by 11.33% to $1.88. The company's market cap stands at $19.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.